Brookstone Capital Management »

Biogen Idec shares owned by Brookstone Capital Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Brookstone Capital Management from 13F filings

Historical chart of Brookstone Capital Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Brookstone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Brookstone Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $4.1M 15k 275.06
2023-03-31 $3.4M 12k 292.19
2022-12-31 $2.4M 8.6k 279.24
2022-09-30 $1.8M 7.2k 253.63
2022-06-30 $1.1M 5.0k 218.71
2022-03-31 $857k 4.1k 210.72
2021-12-31 $502k 2.2k 232.62
2021-09-30 $496k 1.7k 283.59
2021-06-30 $238k 676 352.07
2015-09-30 $7.0k 25 280.00
2015-06-30 $17k 42 404.76